Literature DB >> 15071030

Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.

M A Pfaller1, A Barry, J Bille, S Brown, D Ellis, J F Meis, R Rennie, M Rinaldi, T Rogers, M Traczewski.   

Abstract

An international collaborative study was performed in order to propose quality control limits for voriconazole disk diffusion tests on Mueller-Hinton agar with 2% glucose and 0.5 micro g of methylene blue per ml. The supplement may be added to the agar before autoclaving, or Mueller-Hinton agar plates may be flooded with a glucose-methylene blue solution. Replicate tests on both types of agar plates with 1- micro g voriconazole disks generated data to propose zone size limits for tests of Candida parapsilosis ATCC 22019 (28 to 37 mm), Candida albicans ATCC 90028 (31 to 42 mm), and Candida krusei ATCC 6258 (16 to 25 mm). Candida tropicalis ATCC 750 was not useful for this purpose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071030      PMCID: PMC387608          DOI: 10.1128/JCM.42.4.1716-1718.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

Authors:  M A Pfaller; S A Messer; R J Hollis; R N Jones; D J Diekema
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods.

Authors:  A L Barry; M A Pfaller; R P Rennie; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

Review 5.  Voriconazole: a new triazole antifungal agent.

Authors:  Leonard B Johnson; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2003-02-10       Impact factor: 9.079

6.  Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.

Authors:  A Barry; J Bille; S Brown; D Ellis; J Meis; M Pfaller; R Rennie; M Rinaldi; T Rogers; M Traczewski
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 7.  Voriconazole: a new triazole antifungal agent.

Authors:  Margaret M Pearson; P David Rogers; John D Cleary; Stanley W Chapman
Journal:  Ann Pharmacother       Date:  2003-03       Impact factor: 3.154

Review 8.  Voriconazole -- better chances for patients with invasive mycoses.

Authors:  Mahmoud A Ghannoum; D M Kuhn
Journal:  Eur J Med Res       Date:  2002-05-31       Impact factor: 2.175

Review 9.  In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors:  A Espinel-Ingroff; K Boyle; D J Sheehan
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

  9 in total
  4 in total

1.  In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.

Authors:  Ana Carolina Azevedo; Fernando César Bizerra; Daniel Arquimedes da Matta; Leila Paula de Almeida; Robert Rosas; Arnaldo Lopes Colombo
Journal:  Mycopathologia       Date:  2010-12-23       Impact factor: 2.574

Review 2.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

3.  Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.

Authors:  M A Pfaller; L Boyken; S A Messer; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

4.  Use of Mueller-Hinton broth and agar in the germ tube test.

Authors:  Antonella Souza Mattei; Sydney Hartz Alves; Cecília Bittencourt Severo; Luciana da Silva Guazzelli; Flávio de Mattos Oliveira; Luiz Carlos Severo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.